Market Place
Sourcing Support
Tremeau Pharmaceuticals to Host Key Opinion Leader Webinar on Rofecoxib
20 Oct 2022 //
BUSINESSWIRE
BriOri BioTech Inc. Granted Patent for Topical Formulation of Vioxx
09 Mar 2022 //
BUSINESSWIRE
BriOri BioTech Inc. Granted Patent for Topical Formulation of Rofecoxib
15 Feb 2022 //
BUSINESSWIRE
Tremeau`s Presentations Highlight Unmet Need for Non-Opioid Pain Treatments
13 Dec 2021 //
BUSINESSWIRE
Could Vioxx Make a Comeback? Recalled Drug Receives Orphan Designation
05 Jun 2020 //
PETRIEFLOM
6 Major Drug Recalls from the Past
17 Oct 2019 //
BIOSPACE
Mass. Pharma Company Aims to Give New Life to Shelved Arthritis Drug
11 Oct 2019 //
BIOSPACE
FDA Experts May Reconsider Diabetes Drug Safety Rules
26 Oct 2018 //
FORBES
Study links NSAIDs with higher risk of cardiac arrest
16 Mar 2017 //
PHARMA TIMES
Pharma CEOs, eager for tax breaks and regulatory help, make nice with Trump
01 Feb 2017 //
FIERCE PHARMA
Study Suggests Celebrex Isn’t Riskier Than Rival Pain Drugs
15 Nov 2016 //
WALL STREET JOURNAL
Already facing $200M in damages, J&J seeks to move talc cases out of St. Louis
07 Nov 2016 //
FIERCE PHARMA
Anti-inflammatory pills tied to heart failure risk
21 Oct 2016 //
REUTERS
Pfizer must face revived Celebrex, Bextra safety lawsuit
13 Apr 2016 //
REUTERS
Tylenol Not Effective For Arthritis Pain, Study Concludes
18 Mar 2016 //
FORBES
Merck reaches $830M settlement in long-running Vioxx litigation
16 Jan 2016 //
FIERCE PHARMA
EMA Wants Updated Advice on CV Risk of High-Dose Ibuprofen
21 Apr 2015 //
FDA NEWS
Judge Slams Arthritis Drug Payout Sum
27 Feb 2015 //
9NEWS
Common Pain Drugs Linked To More Problems After A Heart Attack
25 Feb 2015 //
FORBES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.